Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the murine IFN-β gene: Possible role of nitric oxide

Clinical Cancer Research

Volumn 3, Issue 12 I, 1997, Pages 2283-2294

  Xie, Keping ^a   Bielenberg, Diane ^a   Huang, Suyun ^a   Xu, Lei ^a   Salas, Thomas ^a   Juang, Shin Hun ^a   Dong, Zhongyun ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; COLON CARCINOMA; ENZYME INDUCTION; GENETIC TRANSFECTION; KIDNEY CARCINOMA; LUNG METASTASIS; MELANOMA; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

ANIMALS; CARCINOMA, RENAL CELL; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; COLONIC NEOPLASMS; HUMANS; INTERFERON-BETA; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MACROPHAGES; MALE; MELANOMA; MICE; MICE, NUDE; NEOPLASM METASTASIS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031426990     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Baron, S., and Dianzani, F. The interferons: a biological system with therapeutic potential in viral infections. Antiviral Res., 24: 97-110, 1994.
2. Hertzog, P. J., Hwang, S. Y., and Kola, I. Role of interferons in the regulation of cell proliferation, differentiation, and development. Mol. Reprod. Dev., 39: 226-232, 1994.
3. Brzoska, J., and Obert, H-J. Immunomodulating effects of interferons: conclusions for therapy. In: G. Gross, S. Jablonska, H. Pfister, and H. E. Stegner (eds.), Genital Papillomavirus Infections, pp. 379-391. Berlin: Springer-Verlag, 1990.
4. Krown, S. E. Interferons in malignancy: biological products or biological response modifiers? J. Natl. Cancer Inst., 80: 306-309, 1988.
5. Thomas, H., and Balkwill, F. R. Effects of interferons and other cytokines on tumors in animals: a review. Pharmacol. Ther., 52: 307-314, 1991.
6. Gorlach, A., Herter, P., Hentschel, H., Frosch, P. J., and Acker, H. Effects of mIFN-β and rIFN-γ on growth and morphology of two human melanoma cell lines: comparison between two- and three-dimensional culture. Int. J. Cancer, 56: 249-256, 1994.
7. Lokshin, A., Mayotte, J. E., and Levitt, M. L. Mechanism of interferon-beta-induced squamous differentiation and programmed cell death in human non-small-cell lung cancer cell lines. J. Natl. Cancer Inst., 87: 206-210, 1995.
8. Johns, T. G., Mackay, I. R., Callister, K. A., Hertzog, P. J., Devenish, R. J., and Linnane, A. W. Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon-beta. J. Natl. Cancer Inst., 84: 1185-1189, 1992.
9. Sica, G., Fabbroni, L., Castagnetta, L., Cacciatore, M., and Pavone-Macaluso, M. Antiproliferative effect of interferons on human prostate carcinoma cell lines. Urol. Res., 17: 111-117, 1989.
10. Sica, G., Fabbroni, L., Dell'Acqua, G., Iacopino, F., Marchetti, P., Cacciatore, M., and Pavone-Macaluso, M. Natural beta-interferon and androgen receptors in prostatic cancer cells. Urol. Int., 46: 159-164, 1991.
11. Talpaz, M., Rosenbloom, M., Kurzrock, R., Reuben, J., Kantarjian, H., and Gutterman, J. Clinical and laboratory changes induced by alpha Interferon in chronic lymphocytic leukemia-a pilot study. Am. J. Hematol., 24: 341-350, 1987.
12. Gresser, I., Kaido, T., Maury, C., Woodrow, D., Moss, J., and Belardelli, F. Interaction of IFN α/β with host cells essential to the early inhibition of Friend erythroleukemia visceral metastases in mice. Int. J. Cancer, 57: 604-611, 1994.
13. Zhang, J. F., Hu, C., Geng, Y., Blatt, M., and Taylor, M. W. Gene therapy with an adeno-associated virus carrying an interferon gene results in tumor growth suppression and regression. Cancer Gene Ther., 3: 31-38, 1996.
14. Golomb, H., and Ellis, E. Treatment options for hairy-cell leukemia. Semin. Oncol., 18: 7-11, 1991.
15. Einhorn, S., and Grander, D. Why do so many cancer patients fail to respond to interferon therapy? J. Interferon Cytokine Res., 16: 275-281, 1996.
16. Salmon, P., Le Cotonnec, J. Y., Galazka, A., Abdul-Ahad, A., and Darragh, A. Pharmacokinetics and pharmacodynamics of recombinant human interferon-β in healthy male volunteers. J. Interferon Cytokine Res., 16: 759-764, 1996.
17. Fierlbeck, G., Ulmer, A., Schreiner, T., Stroebel, W., Schiebel, U., and Brzoska, J. Pharmacodynamics of recombinant IFN-β during long-term treatment of malignant melanoma. J. Interferon Cytokine Res., 16: 777-781, 1996.
18. Gutterman, J. Cytokine therapeutics: lessons from interferon-α. Proc. Natl. Acad. Sci. USA, 91: 1198-1205, 1994.
19. Grander, D., Xu, B., and Einhorn, S. Cytotoxic effect of interferon on primary tumor cells. Studies in various malignancies. Eur. J. Cancer, 29A: 1940-1943, 1993.
20. Dvorak, H., and Gresser, I. Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice. J. Natl. Cancer Inst., 81: 497-502, 1989.
21. White, C., Sondheimer, H., Crouch, E., Wilson, H., and Fan, L. Therapy of pulmonary hemangiomatosis with recombinant alpha-2a. N. Engl. J. Med., 320: 1197-1200, 1989.
22. White, C. W. Treatment of hemangiomatosis with recombinant interferon-alpha. Semin. Hematol., 27: 15-22, 1990.
23. Ghyka, G., Alecu, M., Halalau, F., and Coman, G. Intralesional human leukocyte interferon treatment alone or associated with IL-2 in non-AIDS related Kaposi's sarcoma. J. Dermatol., 19: 35-39, 1992.
24. Kirn, D. H., and Kramer, A. Long-term freedom from disease progression with interferon alpha therapy in two patients with malignant hemangiopericytoma. J. Natl. Cancer Inst., 88: 764-765, 1996.
25. Folkman, J. The role of angiogenesis in tumor growth. Semin. Cancer Biol., 3: 65-74, 1992.
26. Singh, R. K., Gutman, M., Bucana, C. D., Sanchez, R., Llansa, N., and Fidler, I. J. Interferons alpha and beta downregulate the expression of basic fibroblast growth factor in human carcinomas. Proc. Natl. Acad. Sci. USA, 92: 4562-4569, 1995.
27. Fidler, I. J., and Ellis, L. M. The implications of angiogenesis to the biology and therapy of cancer metastasis. Cell, 79: 185-188, 1994.
28. Oliveira, I. C., Sciavolino, P. J., Lee, T. H., and Vilcek, J. Down-regulation of interleukin-8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon. Proc. Natl. Acad. Sci. USA, 89: 9049-9055, 1992.
29. Van Damme, J., and Opdenakker, G. Interaction of interferons with skin reactive cytokines: from interleukin-1 to interleukin-8. J. Invest. Dermatol., 95: 906-912, 1990.
30. Gohji, K., Fidler, I. J., Tsan, R., Radinsky, R., von Eschenbach, A. C., Tsuruo, T., and Nakajima, M. Human recombinant interferons beta and gamma decrease gelatinase production and invasion by human KG-2 renal carcinoma cells. Int. J. Cancer, 58: 380-387, 1994.
31. Duncan, M. R., and Berman, B. Differential regulation of glycosaminoglycan, fibronectin, and collagenase production in cultured human dermal fibroblasts by interferon-alpha, -beta, and -gamma. Arch. Dermatol. Res., 281: 11-18, 1989.
32. Li, L., Price, J. E., Fan, D., Zhang, R. D., Bucana, C. D., and Fidler, I. J. Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferation capacity at specific metastatic sites. J. Natl. Cancer Inst., 81: 1406-1412, 1989.
33. Gutman, M., Singh, R. K., Xie, K., Bucana, C. D., and Fidler, I. J. Regulation of IL-8 expression in human melanoma cells by the organ environment. Cancer Res., 55: 2470-2475, 1995.
34. Kitadai, Y., Radinsky, R., Bucana, C. D., Takahashi, Y., Xie, K., and Fidler, I. J. Regulation of CEA expression in human colon carcinoma cells by the organ microenvironment. Am. J. Pathol., 749: 1157-1166, 1996.
35. Singh, R. K., Llansa N., Bucana, C. D., Sanchez, R., Koura, A., and Fidler, I. J. Cell density-dependent regulation of basic fibroblast growth factor expression in human renal cell carcinoma cells. Cell Growth Differ., 7: 397-404, 1996.
36. Hart, I. R. Selection and characterization of an invasive variant of the B16 melanoma. Am. J. Pathol., 97: 587-600, 1979.
37. Corbett, T. H., Griswold, J. D. P., Roberts, B. J., Peckham, J. C., and Schabel, J. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays with a note on carcinogen structure. Cancer Res., 35: 2434-2439, 1975.
38. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315-328, 1994.
39. Murphy, G., and Hrushesky, W. J. A murine renal cell carcinoma. J. Natl. Cancer Inst., 50: 1013-1025, 1973.
40. Dong, Z., Qi, X., Xie, K., and Fidler, I. J. Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in LPS-responsive and LPS-nonresponsive murine macrophages. J. Immunol., 151: 2717-2724, 1993.
41. Riches, D. W., and Underwood, G. A. Expression of interferon-beta during the triggering phase of macrophage cytocidal activation. Evidence for an autocrine/paracrine role in the regulation of this state. J. Biol. Chem., 266: 24785-24794, 1991.
42. Ding, A., Nathan, C., and Stuehr, D. J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol., 141: 2407-2412, 1988.
43. Huang, S., Xie, K., Bucana, C. D., Ullrich, S. E., and Bar-Eli, M. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis. Clin. Cancer Res., 2: 1969-1979, 1996.
44. Xie, K., Huang, S., Dong, Z., Juang, S-H., Wang, Y., and Fidler, I. J. Destruction of bystander cells by tumor cells transfected with inducible nitric oxide synthase gene. J. Natl. Cancer Inst., 89: 421-427, 1997.
45. 125I-5-iodo-2′-deoxyuridine. J. Natl. Cancer Inst., 45: 773-782, 1970.
46. Zhang, X., Alley, E. W., Russell, S. W., and Morrison, D. C. Necessity and sufficiency of beta interferon for nitric oxide production in mouse peritoneal macrophages. Infect. Immunol., 62: 33-38, 1994.
47. Taylor-Papadimitriou, J., and Rozengurt, E. Interferons as regulators of cell growth and differentiation. In: J. Taylor-Papadimitriou (ed.), Interferons, Their Impact in Biology and Medicine, pp. 81-94. Oxford: Oxford Medical Publishers, 1985.
48. Kimchi, A. Cytokine triggered molecular pathways that control cell cycle arrest. J. Cell Biochem., 50: 1-9, 1992.
49. Fish, E. N., Ghislain, J., Trogadis, J., and Stevens, J. K. Inhibitory effects of α-interferon on epidermal growth factor-mediated receptor-dependent events. Cancer Res., 53: 5148-5157, 1993.
50. Einat, M., Resnitzky, D., and Kimchi, A. Inhibitory effect of interferon on the expression of genes regulated by platelet-derived growth factor. Proc. Natl. Acad. Sci. USA, 82: 7608-7612, 1985.
51. Lindahl, P., Leary, P., and Gresser, I. Enhancement by interferon of the expression of surface antigens on murine leukemia L1210 cells. Proc. Natl. Acad. Sci. USA, 70: 2785-2788, 1973.
52. 2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc. Natl. Acad. Sci. USA, 75: 6215-6219, 1978.
53. Dustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. D., and Springer, T. A. Induction by IL-1 and interferon-γ: tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J. Immunol., 137: 245-254, 1986.
54. Mentzer, S. J., Faller, D. V., and Burakoff, S. J. Interferon-gamma induction of LFA-1-mediated homotypic adhesion of human monocytes. J. Immunol., 137: 108-113, 1986.
55. Folkman, J. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
56. Sarkar, S., Flores, I., De La Rosa, C., Ozzello, L., Ron, Y., and Pestak, S. Injection of irradiated B16 melanoma genetically modified to secrete IFN-α causes regression of an established tumor. Int. J. Oncol., 7: 17-24, 1995.
57. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB J., 6: 3051-3064, 1992.
58. Li, L., Kilbourn, R. G., Adams, J., and Fidler, I. J. Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res., 51: 2531-2535, 1991.
59. Xie, K., Dong, Z., and Fidler, I. J. Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J. Leukocyte Biol., 59: 797-803, 1996.
60. Xie, K., Huang, S., Dong, Z., Gutman, M., and Fidler, I. J. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. Cancer Res., 55: 3123-3131, 1995.